Professional Summary

Professional Overview

Shelby Brantley is a highly skilled Senior Scientist and Computational Chemist with a strong focus on drug discovery and development. With extensive experience in the pharmaceutical industry, she specializes in leveraging advanced computational techniques to optimize drug candidates and accelerate the drug discovery process.

Experience Summary

Current Role

Shelby currently serves as a Senior Scientist, Computational Chemist at Nereid Therapeutics, a leading biotechnology company based in Boston, Massachusetts. In this role, she is responsible for developing and implementing novel computational modeling and simulation strategies to predict the properties and behaviors of drug candidates. She collaborates closely with interdisciplinary teams to identify and validate promising drug targets, optimize lead compounds, and support the overall drug development pipeline.

Career Progression

Prior to her current role, Shelby held positions as a Senior Scientist I and Scientist II at Jnana Therapeutics, where she made significant contributions to the company's small molecule drug discovery efforts. She also gained valuable experience as a Teaching Assistant and Graduate Research Assistant at the University of Notre Dame, where she honed her expertise in computational chemistry and molecular modeling. Additionally, Shelby completed a successful internship at Relay Therapeutics, further expanding her knowledge and skills in the industry.

Academic Background

Shelby holds a Ph.D. in Chemistry from the University of Notre Dame, where she specialized in computational chemistry and drug design. Her research focused on developing novel computational approaches to predict and optimize the physicochemical properties of drug candidates. Shelby also earned a Bachelor of Science degree in Chemistry from Baylor University, where she conducted undergraduate research in the field of computational chemistry.

Areas of Expertise

• Computational chemistry and molecular modeling

• Drug target identification and validation

• Lead compound optimization and structure-activity relationship (SAR) analysis

• Predictive modeling of physicochemical and pharmacokinetic properties

• Integrated computational and experimental approaches to drug discovery

• Interdisciplinary collaboration and project management

Professional Impact

Throughout her career, Shelby has made significant contributions to the advancement of drug discovery through her innovative computational approaches. She has spearheaded several successful projects that have led to the identification and optimization of promising drug candidates, ultimately accelerating the drug development pipeline. Shelby's research findings have been published in peer-reviewed journals, and she has presented her work at leading industry conferences, demonstrating her commitment to driving progress in the field of computational chemistry.

Conclusion

Shelby Brantley is a highly accomplished Senior Scientist and Computational Chemist with a proven track record of success in the pharmaceutical industry. Her deep expertise in computational chemistry, coupled with her collaborative spirit and drive for innovation, position her as a valuable asset to Nereid Therapeutics and the broader drug discovery community. Shelby is poised to continue making significant contributions to the development of novel and effective therapeutics that improve patient outcomes.